Dodatne informacije

• Lični podaci

• Datum rođenja: 16.10.1971.
• Mesto rođenja: Nis

• Obrazovanje

• Fakultet: Farmaceutski fakultet Univerziteta u Beogradu
• Odsek / Grupa / Smer: diplomirani farmaceut
• Godina diplomiranja: 1995.

• Spisak publikacija

• Knjige i udžbenici:

  1. Радмила Величковић-Радовановић, Александра Цатић-Ђорђевић, Ивана Дамњановић, Никола Стефановић. Приручник из фармакокинетике. Уредник: Радмила Величковић-Радовановић, Медицински факултет Ниш, Ниш, 2015.

  
  

  2. Радмила Величковић-Радовановић, Александра Цатић-Ђорђевић, Ивана Дамњановић (сарадник), Никола Стефановић (сарадник). Фармакоепидемиологија. Уредник: Радмила Величковић-Радовановић, Медицински факултет Ниш, Ниш, 2014

• Radovi u časopisima sa IMPACT faktorom:
  
  
  1. 
     

     Damnjanović I, Stefanović N, Zlatković-Guberinić S, Damnjanović Z, Catić-Đorđević A, Veličković-Radovanović R. Self-medication practices among the patients with chronic venous disease. Farmacia 2020; 68 (2): 225-31.

     
     
  
  
  2. 
     

     Catić-Đorđević A, Pavlović I, Spasić A, Stefanović N, Pavlović D, Damnjanović I, Mitić B, Veličković-Radovanović R. Assessment of pharmacokinetic mycophenolic acid clearance models using Monte Carlo numerical analysis. Xenobiotica 2021; 51(4): 387-393.

     
     
  
  
  3. Stefanović N, Veličković-Radovanović R, Dankovic K, Catić-Đorđević A, Damnjanović I, Mitić B, Cvetković M, Cvetković T. Insight into the potential influence of inter- and intra-individual variability of tacrolimus exposure on graft function decline in three-year period following kidney transplantation. Farmacia 2020; 68 (6): 1036-46.
  
  
  4. Džodić P, Veličković-Radovanović R, Koraćević M, Catić-Đorđević A, Spasić A, Živanović S, Cvetković T. A reliable chromatographic method for the simultaneous determination of ciprofloxacin and moxifloxacin in human serum. Trop J Pharm Res 2020; 19 (10): 2161-9.
  
  
  5. Spasić A, Catić-Đorđević A, Veličković-Radovanović R, Stefanović N, Džodić P, Cvetković T. Adverse effects of mycophenolic acid in renal transplant recipients: gender differences. International Journal of Clinical Pharmacy 2019. In press; DOI:10.1007/s11096-019-00837-z
  
  
  6. Velickovic Radovanovic R, Catic Djordjevic A, Dinic K, Radivojevic J, Zikic O, Cvetkovic T, Mitic B. Metronidazole and levofloxacin induced psychotic disorders in chronic kidney patient. European Journal of Hospital Pharmacy. 2018. In press; DOI: 10.1136/ejhpharm-2018-001677
  
  
  7. Catic-Dordevic A, Pavlovic I, Pavlovic D, Stefanovic N, Mikov M, Cvetkovic T, Velickovic-Radovanovic R. Evaluation of gender-based limited sampling methods for tacrolimus exposure after renal transplantation using the Monte Carlo simulation. Die Pharmazie 2018; 8: 482-485. DOI:10.1691/ph.2018.8461. 
  
  
  8. Catić-Đorđević A, Cvetković T, Stefanović N, Veličković-Radovanović R. Current biochemical monitoring and risk management of immunosuppressive therapy after transplantation. J Med Biochem 2017; 36(1): 1-7. DOI: 10.1515/jomb-2016-0029 
  
  
  9. Veličković-Radovanović RM, Janković SM, Milovanović JR, Catić-Đorđević AK, Spasić AA, Stefanović NZ, Džodić PLj, Šmelcerović AA, Cvetković TP. Variability of mycophenolic acid elimination in the renal transplant recipients – population pharmacokinetic approach. Renal Failure 2015; 37(4): 652-658. DOI: 10.3109/0886022X.2015.1010442 
  
  
  10. Veličković-Radovanović R, Stefanović N, Damnjanović I, Kocić B, Antić S, Dinić M, Petrović J, Mitić R, Catić-Djordjević A. Monitoring of antibiotic consumption and development of resistance by enterobacteria in a tertiary care hospital. J Clin Pharm Ther 2015; 40 (4): 426-430. DOI: 10.1111/jcpt.12283 
  
  
  11. Damnjanovic I, Kitic D, Stefanovic N, Zlatkovic - Guberinic S, Catic - Djordjevic A, Velickovic - Radovanovic R. Herbal self - medication use in patients with diabetes mellitus type 2. Turk J Med Sci 2015; 45 (4): 964-971. DOI: 10.3906/sag-1410-60
  
  
  12. Velickovic-Radovanovic R, Catic-Djordjevic A, Milovanovic JR,et all Population pharmacokinetics of tacrolimus in kidney transplant patients. Int J Clin Pharmacol Ther 2010;48(6):375-82.
  
  
  13. Veličković-Radovanović R, Paunović G , Mikov M, Catic Djordjevic A et all. Clinical Pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy. Basic Clin Pharmacol Toxicol 2010;106(6):505-10. 
  
  
  14. Velickovic-Radovanovic R, Mikov M, Paunovic G, Cvetkovic T, Catic Djordjevic A,et all. Gender Differences in Pharmacokinetics of Tacrolimus and Their Clinical Significance in Kidney Transplant Recipients. Gend Med 2011;8(1):23-31.
  
  
  15. Velickovic-Radovanovic R, Mikov M  ,Catic Djordjevic A, Sojanovic M, Jokanovic M, Stefanovic N, Cvetkovic T. Tacrolimus as a part of immunosuppressive treatment in kidney transplant patients - sex differences. Gender Med 2012. 9(6):471-80.
  
  
  16. Catic Djordjevic A, Velickovic Radovanovic R, Stefanovic N,et al. Interaction between Tacrolimus and Metronidazol in a renal transplant patient. Cent E J Med 2012;7(5)587-90
  
  
  
  

  
  

• Radovi u ostalim časopisima:
  
  
  
  
  1. Koraćević M, Catić-Djordjević A, Stefanović N, Damnjanović I, Stošić I, Veličković-Radovanović R.  Тhe justification of clinical pharmacy skills and knowledge for modern community pharmacist. Acta Medica Medianae 2020; 59(1):14-22.
  
  
  2. Stefanović N, Veličković-Radovanović R, Catić-Djordjević A, Damnjanović I, Dinić K, Mitić B, Jevtović-Stoimenov T, Bašić J, Despotović M, Cvetković T. Interindividual and intraindividual pharmacokinetic variability of tacrolimus within the first year after renal transplantation: effect of CYP3A5 gene polymorphism. Acta Medica Medianae 2019; 58(1): 93-101.
  
  
  3. Catic-Djordjevic A, Pavlovic D, Velickovic-Radovanovic R, Stojanovic D. Probiotics: rational applications, patient opinion and the role of healthcare professionals in their proper selection and use. Acta Medica Medianae 2018; 57(3): 107-13. DOI:10.5633/amm.2018.0315
  
  
  4. Damnjanović I, Kitić D, Stefanović N, Zlatković–Guberinić S, Catić–Đorđević A, Veličković–Radovanović R. The use of herbal dietary supplements in diabetic patients: role of healthcare professionals. Acta Medica Medianae 2017; 56(4):25-30. DOI: 10.5633/amm.2017.0404 
  
  
  5. Džodić P, Veličković-Radovanović R, Šmelcerović A, Catić-Đorđević A, Stefanović N, Spasić A, Ilić D, Živanović S, Ilijev I. Validation of HPLC method for the determination of mycophenolic acid in human plasma obtained from renal transplant recipients. Acta medica Medianae 2016; 55(4): 28-36. DOI:10.5633/amm.2016.0404 
  
  
  6. Veličković-Radovanović R, Stefanović N, Damnjanović I, Petrović J, Mitić R, Lilić R, Kocić B, Antić S, Dinić M, Catić-Đorđević A. Monitoring of the cephalosporins consumption in the tertiary care hospital. Acta medica Medianae 2015; 54(2): 31-36. DOI:10.5633/amm.2015.0205 
  
  
  7. Veličković-Radovanović R, Stefanović N, Damnjanović I, Petrović J, Mitić R, Kocić B, Antić S, Dinić M, Catić-Đorđević A. The Analysis of Antibiotic Consumption and Bacterial Resistance in Tertiary Healthcare Centre Niš. Hospital Pharmacology 2016; 3(1):341-347. DOI:10.5937/HPIMJ1601341V
  
  
  8. Spasić A, Veličković Radovanović R, Catić Đorđević A, Stefanović N, Cvetković T. Quality of Life in Type 2 Diabetic Patients. Acta Facultatis Medicae Naissensis. 2014; 31 (3):193–200.
  
  
  9. Dimitrijević M, Catić-Đorđević A, Stefanović N, Pavlović D, Veličković-Radovanović R. Self-medication in primary healthcare in the territory ofthe city of niš. Acta Medica Medianae 2014; 53(3): 19-24.
  
  
  10. Catić- Đorđević A, Niklolić V, Živanović S, Stefanović N, Veličković- Radovanović R. Carvedilol population pharmacokinetic analysis – applied validation procedure. Acta medica Medianae. 2013; 52(3):18-24.
  
  
  11. Veličković- Radovanović R, Catić-Đorđević A, Paunović G, Đorđević V. Značaj terapijskog praćenja imunosupresivnih lekova kod bolesnika sa presađenim bubregom. Acta Medica Medianae, 2009; 48 (2): 22-7.
  
  
  12. Damnjanović I, Veličković- Radovanović R, Catić- Đorđević A, Kocić R, Ćirić V, Conić I, Bjelaković Lj. Farmakokinetičko i farmakodinamičko modeliranje bazalnih insulina i analoga. Acta Medica Medianae 2009; 48 (1): 15-9.
  
  
  13. Veličković- Radovanović R, Catić-Đorđević A, Dimić M. Klinički značajne farmakokinetičke interakcije antiepileptika, Acta Medica Medianae, 2007;46(4):55-60.
  
  
• Radovi na naučnim skupovima međunarodnog značaja:

  1. Zdravković M, Đorđević J, Catić-Đorđević A, Pavlović S, Ivković M. Case study: univariate time series analysis and forecasting of pharmaceutical products’ sales data at small scale. In: Zdravković M, Konjović Z, Trajanović M. (Eds.) ICIST 2020 Proceedings Vol.1, pp. 1-4, 2020.

  
  

  2.Catić‐Đorđević A, Stefanović N, Veličković‐Radovanović R, STOPP/START CRITERIA FOR OPTIMIZATION OF PHARMACOTHERAPY IN ELDERLY, VII Serbian Congress of Pharmacy with international participation (Arhiv za farmaciju; 68(2): 218 – 219), 10- 14 October 2018, Beograd

  
  

  3. Catić-Đorđević A, Cvetković T, Stefanović N, Veličković-Radovanović R. Monitoring of biochemical parameters in the assessment of immunosuppressive therapy safety. XX Congress of medical biochemistry and laboratory medicine with international participation (Abstract Book in Journal of Medical Biochemistry 2016; 35(2): 186-187) 25-27 May 2016, Belgrade, Serbia

  
  

  4. Velickovic D, Catic-Đordevic A, Herodek R. EVALUATION OF KNOWLEDGE AND ATTITUDES ON DOPING IN SPORT AMONG STUDENTS. XXI International Scientific Conference FIS COMMUNICATIONS 53, 1 (Supplement 1): 16- 19 October 2018, Nis.

  
  

  5. Pavlović D, Stojković J, Velickovic-Radovanovic R, Arsić I, Catić-Djordjević A. The importance of Pharmacy students’ motivation for the future career. III Scientific Symposim”Health Outcomes & Social Pharmacy” Central& Eastern European Symposium. Belgrade 2018, 61-2.
  6. Catić-Djordjević A, Velickovic-Radovanovic R, Stojanović D. Review of medication use and adherence evaluation in elderly patients. III Scientific Symposim”Health Outcomes & Social Pharmacy” Central& Eastern European Symposium. Belgrade 2018, 63-4.
  7.  Spasić A, Catić-Đorđević A, Stefanović N, Veličković-Radovanović R. The influence of mycophenolic acid formulation on the adverse effects in renal transplant recipients. VII Serbian Congress of Pharmacy with international participation (Arhiv za farmaciju); 68(3): 658-659, 10- 14 October 2018, Beograd.
  8. Catic-Djordjevic A, Stefanovic N, Damnjanovic I, Bojanic N, Velickovic-Radovanovic R. Medication review as a tool to optimize prescribing in residential home center for elderly. 35th BALKAN MEDICAL WEEK (Archives of the BALKAN MEDICAL UNION), 53 (Supplement 1): S155 - S156, 25 - 27 September 2018, Athens.
  9. Stefanovic N, Cvetkovic T, Paunovic G, Jevtovic-Stoimenov T, Catic-Djordjevic A, Velickovic-Radovanovic R. Relationship Between Gene Variability of Antioxidative Enzymes and Renal Function Decline in Renal Transplant Recipients: Two Year Post-Transplant Follow-Up. Transplant international 2017; 30 (Suppl 2): 376-376
  10. Damnjanović I, Catić Đorđević A, Stefanović N, Zlatković Guberinić S, Milošević D, Veličković Radovanović R. Influence of health care professionals in preventing medication errors. 50. Days of preventive medicine, 27th-30th September, 2016, Niš, Serbia (Abstract Book: 234)
  11. Stefanovic NZ, Cvetkovic TP, Tatjana M Jevtovic-Stoimenov TM, Catic-Djordjevic AK, Cvetkovic MB, Vujic SS, Velickovic-Radovanovic RM. Superoxide dismutase and glutathione peroxidase genotypes as potential predictors of renal function decline in renal transplant recipients. 53 rd ERA – EDTA Congress, 21-24 May, 2016, Vienna, Austria (Abstract Book: Nephrol Dial Transpl 2016; 31 (Suppl 1): 1575)
  12. Damnjanović I, Kitic D, Stefanovic N, Zlatkovic-Guberinić, Catic-Djordjevic A, Velicković-Radovanović R. Use of herbal dietary supplements in patients with diabetes mellitus type 2. 49. Days of preventive medicine, 22th-25th September, 2015, Niš, Serbia (Abstract Book: 54)
  13. Velickovic–Radovanovic R, Paunovic G, Mitic B, Stefanovic N, Catic-Djordjevic A, Spasic A, Cvetkovic T. : Population pharmacokinetics of mycophenolic acid in renal transplant patients. 12th Congress BANTAO, 15-18 October, 2015, Croatia (Abstract Book: 65)
  14. Stefanovic N, Velickovic–Radovanovic R, Jevtovic–Stoimenov T, Catic Đjordjevic A, Cvetkovic T. The Effect of CYP3A5 and ABCB1 gene polymorphisms on the tacrolimus exposure and renal function in long-term period after renal transplantation. 12th Congress BANTAO, 15-18 October, 2015, Croatia (Abstract Book: 59)
  15. Spasić A, Veličković-Radovanović R, Catić-Đorđević A, Stefanović N, Cvetković T. Effect of mycophenolate mofetil on the hematopoietic system in renal transplant recipients. 75th FIP Centennial Congress, 30 September -3 October 2015, Düsseldorf.
  16. Spasić A, Veličković-Radovanović R, Stefanović N, Janković M, Milovanović J, Catić-Đorđević A, Džodić P. Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipiens. 18th International research conference: Fundamental sciences and clinical medicine - man and health, 18 April 2015, Sankt- Peterburg, ISSN/ISBN 2221-5654, 638-639.
  17. Catić-Djordjević A, Stefanović N, Dimitrijevic M, Damnjanovic I, Nincic J, Veličković-Radovanović R. The role of clinical pharmacist in community pharmacy. VI Serbian congress of pharmacy with international participation, 15 – 10 October, 2014, Serbia (Abstract Book: 231)

  
  

  18. Pavlović D, Stojanović D, Catić-Đorđević A. Self-medication: a current challenge for health professionals. III Scientific Symposim”Health Outcomes & Social Pharmacy” Central& Eastern European Symposium. Belgrade 2018, 45-6.

  
  

  
  
  

• Radovi na domaćim naučnim skupovima:

  1. Catić-Djordjević A, Kocić D, Stefanović N, Veličković-Radovanović R. Adherence in patients with chronic kidney disease. VI week of the hospital clinical pharmacology, 28 - 29 November, 2014, Serbia (Abstract book/Knjiga sažetaka: 20-21.

  
  

  2. Veličković-Radovanović R, Catić-Đorđević A, Paunović G, Đorđević V. Farmakokinetička analiza takrolimusa kod pacijenata sa transplantiranim bubregom. II nedelja bolničke kliničke farmakologije. Beograd. 2010, 17.
  3. Catic-Djordjevic A, Velickovic-Radovanovic R, Stefanovic N, Mitic B, Mikov M.
  Tacrolimus pharmacokinetic profile in renal transplant patients. V week of the hospital clinical pharmacology, 29 November-01 December, 2013, Serbia (oral presentation): 42